Spartalizumab, CAS [[1935694-88-4]]

Produktübersicht

• Artikelname: Spartalizumab, CAS [[1935694-88-4]]
• Artikelnummer: MCE-HY-P9972
• Hersteller Artikelnummer: HY-P9972
• Alternativnummer: MCE-HY-P9972-1MG,MCE-HY-P9972-5MG,MCE-HY-P9972-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: PDR001

Produktbeschreibung

Spartalizumab (PDR001) is a humanized IgG4 monoclonal antibody. Spartalizumab binds to PD-1 at picomolar affinity and blocks the interactions with PD-L1 and PD-L2, thereby relieving the inhibition on T cell activity and restoring the immune systems ability to attack tumors. Spartalizumab can be used in the research of undifferentiated thyroid carcinoma (ATC) and neuroendocrine tumors (NENs)[1][2].

Produkteigenschaften

• Molekulargewicht: (143.14 kDa)
• Reinheit: 99.50
• CAS Nummer: [1935694-88-4]
• Target-Kategorie: PD-1/PD-L1

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies